1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kohda, D.
Terasawa, H.
Hatanaka, H.
Inagaki, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure
STRUE6
2005
0969-2126
2
1029
1040
10.1016/S0969-2126(94)00106-5
7881903
Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2.
1994
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6785.427
GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2
1
man
polymer
no
no
GSTYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNR
GSTYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
GRB2
9606
Homo sapiens
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1994-08-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1994-06-13
REL
1
BRUNGER
refinement
X-PLOR
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
THR
3
n
3
THR
3
A
TYR
4
n
4
TYR
4
A
VAL
5
n
5
VAL
5
A
GLN
6
n
6
GLN
6
A
ALA
7
n
7
ALA
7
A
LEU
8
n
8
LEU
8
A
PHE
9
n
9
PHE
9
A
ASP
10
n
10
ASP
10
A
PHE
11
n
11
PHE
11
A
ASP
12
n
12
ASP
12
A
PRO
13
n
13
PRO
13
A
GLN
14
n
14
GLN
14
A
GLU
15
n
15
GLU
15
A
ASP
16
n
16
ASP
16
A
GLY
17
n
17
GLY
17
A
GLU
18
n
18
GLU
18
A
LEU
19
n
19
LEU
19
A
GLY
20
n
20
GLY
20
A
PHE
21
n
21
PHE
21
A
ARG
22
n
22
ARG
22
A
ARG
23
n
23
ARG
23
A
GLY
24
n
24
GLY
24
A
ASP
25
n
25
ASP
25
A
PHE
26
n
26
PHE
26
A
ILE
27
n
27
ILE
27
A
HIS
28
n
28
HIS
28
A
VAL
29
n
29
VAL
29
A
MET
30
n
30
MET
30
A
ASP
31
n
31
ASP
31
A
ASN
32
n
32
ASN
32
A
SER
33
n
33
SER
33
A
ASP
34
n
34
ASP
34
A
PRO
35
n
35
PRO
35
A
ASN
36
n
36
ASN
36
A
TRP
37
n
37
TRP
37
A
TRP
38
n
38
TRP
38
A
LYS
39
n
39
LYS
39
A
GLY
40
n
40
GLY
40
A
ALA
41
n
41
ALA
41
A
CYS
42
n
42
CYS
42
A
HIS
43
n
43
HIS
43
A
GLY
44
n
44
GLY
44
A
GLN
45
n
45
GLN
45
A
THR
46
n
46
THR
46
A
GLY
47
n
47
GLY
47
A
MET
48
n
48
MET
48
A
PHE
49
n
49
PHE
49
A
PRO
50
n
50
PRO
50
A
ARG
51
n
51
ARG
51
A
ASN
52
n
52
ASN
52
A
TYR
53
n
53
TYR
53
A
VAL
54
n
54
VAL
54
A
THR
55
n
55
THR
55
A
PRO
56
n
56
PRO
56
A
VAL
57
n
57
VAL
57
A
ASN
58
n
58
ASN
58
A
ARG
59
n
59
ARG
59
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
27
A
N
ILE
27
A
O
VAL
5
A
O
VAL
5
A
N
GLN
6
A
N
GLN
6
A
O
THR
55
A
O
THR
55
A
N
PHE
11
A
N
PHE
11
A
O
PHE
21
A
O
PHE
21
A
O
ASP
31
A
O
ASP
31
A
N
LYS
39
A
N
LYS
39
A
O
TRP
38
A
O
TRP
38
A
N
PHE
49
A
N
PHE
49
1
A
ARG
22
0.197
SIDE CHAIN
1
A
ARG
23
0.259
SIDE CHAIN
1
A
ARG
51
0.319
SIDE CHAIN
1
A
ARG
59
0.179
SIDE CHAIN
1
-6.21
1.00
110.10
103.89
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
37
37
37
N
1
5.93
0.90
109.00
114.93
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
37
37
37
N
1
8.13
1.10
130.40
138.53
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
37
37
37
N
1
-6.20
1.00
107.30
101.10
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
37
37
37
N
1
-6.92
1.00
110.10
103.18
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
38
38
38
N
1
6.42
0.90
109.00
115.42
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
38
38
38
N
1
9.80
1.10
130.40
140.20
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
38
38
38
N
1
-6.84
1.00
107.30
100.46
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
38
38
38
N
1
-6.28
0.90
133.90
127.62
A
A
A
CG
CD2
CE3
TRP
TRP
TRP
38
38
38
N
1
A
A
CG
ND1
HIS
HIS
28
28
-0.100
0.015
1.369
1.269
N
1
A
A
CG
CD2
TRP
TRP
38
38
-0.106
0.017
1.432
1.326
N
1
A
A
CG
ND1
HIS
HIS
43
43
-0.102
0.015
1.369
1.267
N
1
A
ALA
7
-24.38
109.76
1
A
PRO
13
-43.63
161.04
1
A
GLN
14
-155.00
-5.66
1
A
ARG
23
-14.98
136.03
1
A
VAL
29
-64.03
88.95
1
A
ASP
31
-171.78
97.74
1
A
ASN
32
-58.42
109.47
1
A
SER
33
-98.20
-75.48
1
A
CYS
42
-169.95
-87.18
1
A
HIS
43
-63.74
72.59
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2 (GRB2) (C-TERMINAL SH3 DOMAIN) (NMR, MINIMIZED MEAN STRUCTURE)
SOLUTION STRUCTURE AND LIGAND-BINDING SITE OF THE C-TERMINAL SH3 DOMAIN OF GRB2
1
Y
N
A
ARG
51
A
ARG
51
HELX_P
3/10 HELIX
A
TYR
53
A
TYR
53
5
GH
3
ADAPTOR PROTEIN CONTAINING SH2 AND SH3
ADAPTOR PROTEIN CONTAINING SH2 AND SH3
GRB2_HUMAN
UNP
1
1
P62993
MEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIEMKPHPWFFGKIPRAKAEEMLSKQRHD
GAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTY
VQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNRNV
159
215
1GFC
3
59
P62993
A
1
3
59
3
2
3
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
ASP
25
A
ASP
25
A
VAL
29
A
VAL
29
A
TYR
4
A
TYR
4
A
ALA
7
A
ALA
7
A
VAL
54
A
VAL
54
A
PRO
56
A
PRO
56
A
PHE
9
A
PHE
9
A
ASP
12
A
ASP
12
A
GLY
20
A
GLY
20
A
ARG
22
A
ARG
22
A
ASP
31
A
ASP
31
A
ASN
32
A
ASN
32
A
TRP
37
A
TRP
37
A
CYS
42
A
CYS
42
A
GLN
45
A
GLN
45
A
PRO
50
A
PRO
50
1
P 1